/
2015 ISC Hot Topics- Advancing Your Stroke Program 2015 ISC Hot Topics- Advancing Your Stroke Program

2015 ISC Hot Topics- Advancing Your Stroke Program - PowerPoint Presentation

goldengirl
goldengirl . @goldengirl
Follow
342 views
Uploaded On 2020-08-28

2015 ISC Hot Topics- Advancing Your Stroke Program - PPT Presentation

Debbie Summers MSN RN ACNSBC CNRN SCRN FAHA ANVP Saint Lukes Hospital Kansas City MO Speaker Debbie Summers Topic 2015 ISC Hot Topics Advancing Your Stroke Program Disclosure ID: 807534

clinical stroke research collateral stroke clinical collateral research care flow collaterals ischemic trials time grade patients score therapy print

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "2015 ISC Hot Topics- Advancing Your Stro..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

2015 ISC Hot Topics- Advancing Your Stroke Program

Debbie Summers, MSN, RN, ACNS-BC, CNRN, SCRN, FAHA, ANVPSaint Luke’s Hospital Kansas City, MO

Slide2

Speaker: Debbie Summers

Topic: 2015 ISC Hot Topics- Advancing Your Stroke Program

Disclosure:

Covidien LtdConsultant

2

Slide3

Objectives

Apply new research topics presented at the International Stroke Conference

Discuss the relevance of at least two new practices that may influence their own program/practice

Slide4

Forum for:

Disseminating clinical stroke trial results and Sharing of best practices within the field

Occurs annually in February

Pre-conferences 1day prior to meeting:Stroke in the Real World: Challenges to inpatient stroke care 2015

Emerging Trends for stroke trials

Option to submit abstracts, projects and research is open to everyone at Strokeconference.org

ISC – What is it?

And Why is it important?

Slide5

Slide6

The Changing Landscape of Stroke Treatment

Slide7

IMS III

No clear benefit to intraarterial

(IA) therapy

Confirmation of occlusion was not required at the time of randomization, and 23% of the patients in the IA arm did not receive treatmentTime to IA treatment was longer than 2 earlier trials potentially mitigating the benefit Limited use of new technologies (5 stent retrievers) Full dose tPA only used in amendment 5 Future trials are needed to determine whether any patient groups benefit from IA treatment

Broderick JP et al. Stroke. NEJM 2013;368:893-903

Slide8

8

|

++Broderick,

Joeseph

, et. Al. Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. NEJM. vol. 368 no. 10

IMS III did show that better revascularization leads to improved outcomes.++

TICI=0

TICI=1

TICI=2a

TICI=2b

TICI=3

% 90 Day

mRS

0-2

N=32

N=16

N=67

N=80

N=5

3.1%

12.5%

19.4%

46.3%

80%

6.3%

35.5%

P < .0001

13.9%

48.2%

P < .0001

Slide9

Differences between the two treatment groups across the entire distribution of the

mRS

(

p =

0.06

,

van

Elterin

test)

IMS3 Did show an improvement in

mRS

0-2 at 90 days for

patients presenting with more severe strokes.++

++Broderick,

Joeseph

, et. Al. Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. NEJM. vol. 368 no. 10

Slide10

IMS III Take-

Aways

Use of newer stent

thrombectomy devices may improve long term neurological outcomes when studied in future randomized studies by providing higher rates of procedural recanalizationEnrollment of confirmed large vessel occlusions, particularly ICA occlusions and patients with a higher incoming NIHSS score should represent a population more likely to benefit from endovascular therapy.

Slide11

Up to date technology:

Stent Retrievers

Slide12

Clinical Trials – Mr. Clean

Slide13

Slide14

Slide15

Slide16

Slide17

Slide18

Clinical Trials – ESCAPE

Slide19

Clinical Trials – EXTEND IA

Slide20

Clinical Trial – SWIFT PRIME

Slide21

Trial

Summary

Slide22

Lancet Neurol.

 2014 Jun;13(6):567-74

Increased time to reperfusion was associated with a decreased likelihood of good clinical outcome (unadjusted relative risk for every 30-min delay 0·85 [95% CI 0·77–0·94]; adjusted relative risk 0·88 [0·80–0·98]).

Slide23

Khatri P. Neurology 2009; 73 (13): 1066-1072

Slide24

Time is Brain Stroke Systems of Care

Slide25

We Have to Get Organized…

• Pre-hospital Systems of Care

Community education for symptoms & EMS activation

EMS education for recognition and empowered for activation to higher level centersPrimary to comprehensive center networkLimiting community hospital time/transfer time

Efficient in-house triage, activation, treatment with endovascular to ≤ 90 minutes

Slide26

Manipulating the time window

• Increasing collateralization

Increasing Venous return/Volume – NS bolus

Attention to BPPositioningBalloon pumps/mechanical counter-pulsationNeuroprotection

agents; hypothermia

Slide27

Slide28

Collaterals

Numerous stroke clinical trials are demonstrating the profound impact of collaterals

Recanalization

ReperfusionSmaller infarctsLess hemorrhagic transformationBetter clinical outcomes

Slide29

The Future

We have gone from our first generation of clot removing procedures, which were only moderately good in reopening target arteries, to now having highly effective tools. Imaging from non-contrast CT to identification of salvageable tissue to looking at collateral flow.

Slide30

Collateral Flow Grading

Slide31

American Society of Interventional and Therapeutic

Neuroradiology Collateral Grading System

Grade

Cerebral

Collateral Flow Grading

Description

Grade 0

no collaterals visible to ischemic site

Grade 1

slow collaterals to the periphery of the ischemic site with persistence of defect

Grade 2

rapid collaterals to the periphery of ischemic site with persistence of some of the defect and to only a portion of the ischemic territory

Grade 3

collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase

Grade 4

complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion

Slide32

Collateral Flow with Time

Slide33

The Future

Collateral therapeutics may entail use of readily available hemodynamic manipulations such as head positioning, hypervolemia

, hypertensive therapy, or partial aortic obstruction in selected cases.

Slide34

Theory of Collateral Flow

The connection between

leptomeningeal

collateral flow (LMF) and the survival of brain parenchyma during acute ischemia has been confirmed in a large number of clinical studies  Bang OY. Stroke. 2011;42:2235-2239.

Slide35

Collaterals Avert HT

Data revealed that therapeutic recanalization in the setting of poor collaterals resulted in a high frequency of HT with worsened clinical neurological status.

Poor collateral status at baseline may limit effective reperfusion, even when

recanalization is successful.Bang OY. Stroke. 2011;42:2235-2239.

Slide36

CTA to Obtain Collateral Flow

Slide37

10 point quantitative topographic CT scan score to assess early ischemic changes of the MCA region

Assessed at 2 standardized regionsGanglionic Level where the thalamus, basal ganglia and caudate are visible Supraganglionic

level which includes the corona

radiata and centrum semiovale

Alberta

Stroke

Program

Early

CT

Score

(ASPECT)

Slide38

Slide39

Normal ASPECT score

is 10 Deduct 1 point for each area involved.

A score of 7 or less

Correlates with poor functional outcome and hemorrhage.

*Limitation – Only scores the MCA

ASPECT

score

Slide40

HOUSTON MSU Standard 12 foot ambulance

Slide41

Slide42

BEST MSU Study

Benefits of Stroke

T

reatment Delivered Using a Mobile Stroke Unit Compared to Standard Management by EMS Aims

Determine the logistic and clinical outcomes of MSU

vs

SM in the U.S. – speed, #, first hour.

Can MD/Nurse be replaced by Telemedicine?What is the Cost Effectiveness?

Slide43

WHY is Nursing

Research I

mportant?

Build the scientific foundation for clinical practicePrevent disease and disabilityManage and eliminate symptoms caused by illness

Slide44

Home Care

Nutrition

Acute Rehab/SNF

Pharmacy

STROKE Program

Social Work/Clinical Resource Management

Physical Therapy

Palliative Care Hospice

Multidisciplinary Care

Primary Care

Family

Care Givers

Community Resources

Slide45

Steps in Research

Process

Identify the problem or question.

Does Red Print or Blue print on patient education materials improve patients retention of knowledge?Review the literatureLit search on patient education materials and retention – variables that influenceDevelop hypothesis

Red print educational materials result in higher stroke knowledge retention

Methodology - Decide how you will investigate the question/hypothesis?

50 patients will be given red print and 50 patients will be given black print. A post test will be developed and provided. Variables such as age, race, sex, highest completed education, NIHSS will be collected in addition to results.

Slide46

Research Design

Retrospective

versus

Prospective research

Use of Databases

Get With The Guidelines-Stroke

University Health Consortium (UHC)

Home grown databases

Slide47

Steps in Research

Process

Institutional Review Board (IRB)process.

Implement methodology/collect dataAnalyze results - statistics

Slide48

Steps in Research

Process

Draw conclusions

Share conclusionsImplement change

Slide49

Integrating Research Findings

One example is the updates to clinical practice guidelines – developed by AHA/ASA work groups.

When published, we need to compare to current practice

Discuss gaps/changes recommended in stroke team meetingsWork with E record, nursing focus groups, etcChange protocols, documentation records, educate all team membersMeasure

Slide50

Slide51

Nursing Symposium

Slide52

Slide53

Slide54

Slide55

Slide56

Slide57

Slide58

Slide59

Slide60

Slide61

Slide62

Slide63

Slide64

Slide65

Slide66

Slide67

Slide68

Slide69

Slide70

Slide71

Slide72

Slide73

Georgia Stroke Professional Alliance

Slide74

Slide75

Slide76

Slide77

Slide78

Slide79

Slide80

Slide81

Slide82

Slide83

Gulf Coast Medical Center

Slide84

Reducing Readmission Rates

Higher than national average readmission rates (Range 14.9%-18.6%)

Implemented discharge rounds to decrease rate

Evolution of processPhone conference decreased from 18% to 8.9%Unit level conference further decreased to 8.4%Bedside, nurse led DC rounds further decreased to as low as 5.3%Rounding tool usedPT, OT, SLP recommendations

New medications

DC

plan – social/family

concerns

Slide85

Nursing Symposium

Many more….

Nursing & EMS – Bridging the great divide

Head up vs head down in acute strokeEvaluating care giver needsTransitions of carePalliative careToo many to review all!!

Slide86

Slide87

Slide88

2016 Call for abstracts:

May 20- Aug 11, 2015

Slide89